PriceTracker GLP-1
Loading the index…

Try

Loading the index…

Try

GLP-1 TV · Patient story · views checked Oct 2026

Ozempic Month 5 Update || Weight loss, labs, side effects & even more controversy

Patient storyAuthor Emily Shacklette12,721 views10:30Feb 2023

Our summary

In this month five update, Emily Shacklette says she was prescribed Ozempic by her primary care provider for pre-diabetes, citing a genetic predisposition and labs that were not great. She stresses she is not taking it specifically for weight loss, though she says she has lost weight. She recaps her dosing: about two months on 0.25 mg, then 0.5 mg, and now 1 mg. She says December on 0.5 mg brought her first digestive issues and no weight loss, which she links to holiday sugar, cookies and less exercise.

One person's experience, in their words. Not medical advice.

What else the video covers

For January on 1 mg, she says the injection burns much more than it did at lower doses. She felt nothing at 0.25 mg and a little at 0.5 mg. Tips she tried, such as letting the pen warm up after refrigeration and pinching the skin, did not help, and she ends up slightly bruised. Her main side effect is a loss of interest in food, close to nausea, after her Tuesday injection. It eases by Thursday and she feels normal by Friday. She says she relies on protein shakes and Chipotle during that stretch, and that she had no digestive problems this month.

On weight, she says her home scale showed no change in December, while a gynecologist's scale showed a gain of four or five pounds. By her home scale the day before filming, she was down six pounds from that holiday gain, which she attributes mostly to water weight. She has no lab update because her primary care provider is on maternity leave until April, and results from the gynecologist's labs are still pending. The original plan was one year, September 2022 to September 2023, with a check-in in April. She also recommends a podcast episode featuring Jameela Jamil on diet culture.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 0:30 She says she takes Ozempic for pre-diabetes, not primarily for weight loss, and has lost weight on it.
  2. 1:01 She describes her dose steps: 0.25 mg for about two months, then 0.5 mg, now 1 mg.
  3. 2:15 At 1 mg she says the injection burns far more than at lower doses, and tips she tried did not help.
  4. 3:37 She reports appetite loss and near-nausea after her Tuesday injection that fades by Friday.
  5. 6:42 By her home scale she is down six pounds from a four or five pound holiday gain, which she links to water weight.
  6. 8:32 She has no new lab results and will review the one-year plan with her doctor in April.

Key moments

From the creator's own chapters. Tap one to play from there.

  1. 0:00 Introduction and context
  2. 1:18 Dosage increase and pain
  3. 3:22 Side effects and diet
  4. 5:15 Weight loss journey
  5. 7:15 Future plans and closing

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Ozempic
Doses mentioned
0.25 mg
Point in the journey
Month 5
Who is speaking
Patient

Questions this video answers

Does Ozempic 1 mg injection hurt more than lower doses?

Emily says it does. She felt nothing at 0.25 mg and a little at 0.5 mg, but says 1 mg burns badly. Warming the pen after refrigeration and pinching the skin did not help her, and she ends up a little bruised.

What side effects did she have on Ozempic 1 mg?

She says the main one is disinterest in food, almost like nausea, after her Tuesday injection. It lasts a few days and she feels normal by Friday. She reports no digestive issues this month.

How long is she planning to stay on Ozempic?

She says the original plan was one year, from September 2022 to September 2023. She and her primary care provider plan a check-in in April to decide whether that still makes sense.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Ozempic for weight loss, and where the ladder runs out

    Ozempic is approved for type 2 diabetes, not for weight loss. Taking it to lose weight is off-label, which is legal, extremely common, and a prescriber's decision. The consequence nobody mentions is the ceiling: Ozempic's doses stop at 2 mg while Wegovy, the same molecule approved for weight, goes to 2.4 mg with a 7.2 mg strength above that. Someone using Ozempic for weight eventually runs out of ladder, and switching brand is the usual answer.

  • Ozempic dosage chart: 0.25 mg to 2 mg, every pen, the missed-dose rule, and what each dose costs

    Ozempic starts at 0.25 mg once a week for four weeks, then goes to 0.5 mg. If more blood sugar control is needed after at least four weeks, it can go to 1 mg, and after four more weeks to 2 mg, the maximum. Paying cash through NovoCare it is $199 for each of the first two months, then $349 a month up to 1 mg and $499 at 2 mg.

  • Mounjaro vs Ozempic, and the trial everyone quotes about it

    Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.

Find more like it

Side effectsWeigh-in and resultsFood, protein and eating

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV